Creative Planning Incyte Corp Transaction History

Creative Planning

  • $129 Billion
  • Q3 2025

A detailed history of Creative Planning transactions in Incyte Corp stock. As of the latest transaction made, Creative Planning holds 59,299 shares of INCY stock, worth $6.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,299
Previous 33,106 79.12%
Holding current value
$6.18 Million
Previous $2.25 Million 123.11%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$67.27 - $86.96 $1.76 Million - $2.28 Million
26,193 Added 79.12%
59,299 $5.03 Million
Q2 2025

Aug 08, 2025
BUY
$55.17 - $71.22 $295,931 - $382,024
5,364 Added 19.34%
33,106 $2.25 Million
Q1 2025

May 15, 2025
BUY
$60.0 - $75.26 $21,360 - $26,792
356 Added 1.3%
27,742 $1.68 Million
Q4 2024

Feb 14, 2025
BUY
$65.08 - $83.38 $326,701 - $418,567
5,020 Added 22.44%
27,386 $1.89 Million
Q3 2024

Oct 11, 2024
BUY
$57.33 - $68.61 $74,930 - $89,673
1,307 Added 6.21%
22,366 $1.48 Million
Q2 2024

Aug 15, 2024
BUY
$51.18 - $63.75 $127,745 - $159,120
2,496 Added 13.45%
21,059 $1.28 Million
Q1 2024

May 10, 2024
BUY
$56.55 - $66.59 $194,588 - $229,136
3,441 Added 22.75%
18,563 $1.06 Million
Q4 2023

Feb 14, 2024
BUY
$52.16 - $64.19 $242,231 - $298,098
4,644 Added 44.32%
15,122 $949,000
Q3 2023

Nov 16, 2023
BUY
$57.77 - $65.93 $44,829 - $51,161
776 Added 8.0%
10,478 $605,000
Q2 2023

Jul 21, 2023
BUY
$60.95 - $75.51 $118,730 - $147,093
1,948 Added 25.12%
9,702 $603,000
Q1 2023

May 15, 2023
SELL
$70.23 - $86.01 $8,778 - $10,751
-125 Reduced 1.59%
7,754 $560,000
Q4 2022

Feb 10, 2023
SELL
$67.18 - $84.11 $49,108 - $61,484
-731 Reduced 8.49%
7,879 $632,000
Q3 2022

Nov 03, 2022
SELL
$66.18 - $82.86 $88,747 - $111,115
-1,341 Reduced 13.48%
8,610 $574,000
Q2 2022

Aug 15, 2022
BUY
$66.18 - $83.18 $217,732 - $273,662
3,290 Added 49.39%
9,951 $756,000
Q1 2022

May 16, 2022
SELL
$66.02 - $79.71 $127,484 - $153,920
-1,931 Reduced 22.47%
6,661 $529,000
Q4 2021

Feb 11, 2022
BUY
$63.34 - $74.11 $78,858 - $92,266
1,245 Added 16.95%
8,592 $631,000
Q3 2021

Nov 10, 2021
BUY
$68.67 - $84.02 $2,540 - $3,108
37 Added 0.51%
7,347 $505,000
Q2 2021

Aug 04, 2021
BUY
$79.87 - $87.53 $18,050 - $19,781
226 Added 3.19%
7,310 $615,000
Q1 2021

Apr 30, 2021
SELL
$76.02 - $100.5 $32,536 - $43,014
-428 Reduced 5.7%
7,084 $576,000
Q4 2020

Jan 29, 2021
BUY
$80.74 - $97.7 $32,295 - $39,080
400 Added 5.62%
7,512 $653,000
Q3 2020

Nov 05, 2020
BUY
$85.07 - $109.69 $29,008 - $37,404
341 Added 5.04%
7,112 $638,000
Q2 2020

Jul 23, 2020
SELL
$74.18 - $108.93 $14,761 - $21,677
-199 Reduced 2.86%
6,771 $704,000
Q1 2020

May 05, 2020
SELL
$63.18 - $85.97 $96,728 - $131,620
-1,531 Reduced 18.01%
6,970 $510,000
Q4 2019

Jan 30, 2020
SELL
$73.04 - $95.72 $304,576 - $399,152
-4,170 Reduced 32.91%
8,501 $742,000
Q3 2019

Nov 01, 2019
BUY
$72.82 - $86.52 $169,306 - $201,159
2,325 Added 22.47%
12,671 $941,000
Q2 2019

Jul 26, 2019
SELL
$73.52 - $88.7 $84,327 - $101,738
-1,147 Reduced 9.98%
10,346 $879,000
Q1 2019

Apr 24, 2019
BUY
$63.56 - $88.17 $83,390 - $115,679
1,312 Added 12.89%
11,493 $989,000
Q4 2018

Feb 01, 2019
SELL
$58.5 - $69.94 $640,282 - $765,493
-10,945 Reduced 51.81%
10,181 $647,000
Q3 2018

Oct 25, 2018
SELL
$61.75 - $74.23 $250,334 - $300,928
-4,054 Reduced 16.1%
21,126 $1.46 Million
Q2 2018

Jul 20, 2018
BUY
$60.85 - $83.98 $263,358 - $363,465
4,328 Added 20.76%
25,180 $1.69 Million
Q1 2018

Apr 18, 2018
BUY
$83.06 - $100.98 $263,632 - $320,510
3,174 Added 17.95%
20,852 $1.74 Million
Q4 2017

Jan 17, 2018
BUY
$93.56 - $116.6 $388,461 - $484,123
4,152 Added 30.7%
17,678 $1.67 Million
Q3 2017

Oct 17, 2017
BUY
$109.15 - $138.27 $1.48 Million - $1.87 Million
13,526
13,526 $1.58 Million

Others Institutions Holding INCY

# of Institutions
795
Shares Held
205M
Call Options Held
638K
Put Options Held
635K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email